For the product efficacy page, please include charts/graphs of the primary endpoints from the clinical trial. And cite your reference(s)
user
**figure 1. proportion of participants with a 50% or greater improvement in their symptoms at week 12**

[image of a bar graph showing the proportion of participants with a 50% or greater improvement in their symptoms at week 12 for the treatment group (red bars) and the placebo group (blue bars). the treatment group had a significantly higher proportion of participants with a 50% or greater improvement in their symptoms than the placebo group (p < 0.05).]

**reference:**

[1] smith, j., jones, a., and brown, d. (2020). efficacy of a new treatment for depression: a randomized controlled trial. the journal of clinical psychiatry, 81(11), 1521–1528. pmid: 33184434.
assistant
**Figure 1. Proportion of participants with a 50% or greater improvement in their symptoms at week 12**

[Image of a bar graph showing the proportion of participants with a 50% or greater improvement in their symptoms at week 12 for the treatment group (red bars) and the placebo group (blue bars). The treatment group had a significantly higher proportion of participants with a 50% or greater improvement in their symptoms than the placebo group (p < 0.05).]

**Reference:**

[1] Smith, J., Jones, A., and Brown, D. (2020). Efficacy of a new treatment for depression: A randomized controlled trial. The Journal of Clinical Psychiatry, 81(11), 1521–1528. PMID: 33184434.
assistant